Fennec Pharmaceuticals Inc.FENCNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank86
3Y CAGR+168.0%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+168.0%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
19.2x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 97.28% |
| 2023 | 29.55% |
| 2022 | -32.46% |
| 2021 | 5.06% |
| 2020 | -38.53% |
| 2019 | -32.20% |
| 2018 | -40.33% |
| 2017 | -152.64% |
| 2016 | -323.22% |
| 2015 | 69.72% |